Cargando...
DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia
BACKGROUND: Downstream of tyrosine kinase 6 (DOK6), which is specifically expressed in the nervous system, was previously recognized as an adapter only in neurite outgrowth. Recent studies also demonstrated the potential role of DOK6 in solid tumors such as gastric cancer and breast cancer. However,...
Gardado en:
| Publicado en: | Cancer Med |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6797566/ https://ncbi.nlm.nih.gov/pubmed/31486300 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2540 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|